Deep inside a carpenter ant nest, something far more sophisticated than formic acid is at work keeping pathogens at bay. Researchers from Freie Universität Berlin have discovered that the venom of carpenter ants contains not a simple chemical weapon, but a complex arsenal of 35 distinct antimicrobial peptides—compounds so powerful they're reshaping how scientists understand both insect immunity and the future of human medicine.
For nearly four centuries, ever since formic acid was first isolated from Formica ants in the seventeenth century, scientists assumed they had solved the puzzle of ant venom. The story seemed straightforward: these insects produced acid, the acid killed germs, and that was that. But Timo Niedermeyer, a professor of pharmaceutical biology at Freie Universität Berlin, and his team stumbled onto a decades-old publication that had been largely forgotten—one that mentioned something else in ant venom, something peptidic. When they decided to take it seriously and investigate, everything changed.
The researchers examined venom samples from eight geographically distant species of carpenter ants and identified thirty-five peptides belonging to two distinct gene families, which they named formicitoxins. What surprised them most was not just the number of peptides, but how consistent their presence was across species—even as the specific composition of each formicitoxin varied from one ant species to another. "Carpenter ant venom is considerably more complex than previously assumed," Niedermeyer explains in the research published in Science Advances.
This discovery matters because it reveals how ants have engineered an elegant solution to a problem humans are still struggling with: pathogenic resistance. Carpenter ants don't just spray their nests with venom and hope for the best. Instead, they strategically coat their brood and nesting areas with these peptides, creating a persistent antimicrobial barrier that continues protecting the colony long after the immediate antimicrobial effects of formic acid have faded. Some formicitoxins show remarkable antifungal properties—a finding that resonates urgently with the growing threat of microbial resistance in human medicine.
"This is particularly interesting when we consider the increased threat of microbial resistance for human well-being," emphasizes Dr. Simon Tragust from Martin Luther University Halle-Wittenberg, another lead researcher on the project. The scale of what they've uncovered is staggering. The Formicinae subfamily alone comprises over 3,700 ant species, meaning the researchers have likely only scratched the surface of what nature has engineered across the insect world.
To untangle this complexity, the research team combined cutting-edge methods from biology, chemistry, and pharmacy. They used proteotranscriptomic approaches to merge protein and RNA data, performed chemical analyses, synthesized their own formicitoxins, and employed biophysical experiments and computer modeling to understand the structure and evolutionary history of what they'd found. The thoroughness of their interdisciplinary approach—examining venom from multiple colonies—makes this one of the most comprehensive comparative analyses of ant venom ever conducted.
The implications ripple outward from the ant nest. These peptides hint at new possibilities for medical research, shed light on how social insect communities manage microbes collectively, and suggest that nature has been solving the antibiotic resistance problem for millions of years. What carpenter ants learned through evolution, we may now have the chance to understand.